Neurobehavioral consequences of prenatal antiepileptic drug exposure

Caroline Elizabeth Nadebaum, Vicki Anne Anderson, Frank John Emery Vajda, David Charles Reutens, Amanda Gabrielle Wood

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


Despite elevated rates of birth defects associated with prenatal antiepileptic drug exposure, pharmacotherapy is typically continued throughout pregnancy because of the risks posed to mother and child by recurrent seizures. Emerging data suggest that prenatal exposure to valproate or polytherapy may also be associated with increased risk of cognitive impairment. However, our understanding of the longer-term sequelae of prenatal antiepileptic drug exposure remains incomplete. Improved understanding of the neurobehavioral consequences of prenatal antiepileptic drug exposure is essential to ensure accurate information is available for women with epilepsy planning a pregnancy, and to achieve optimal outcomes for mothers and children.
Original languageEnglish
Pages (from-to)1 - 29
Number of pages29
JournalDevelopmental Neuropsychology
Issue number1
Publication statusPublished - 2012

Cite this